- Purple Biotech ( NASDAQ: PPBT ) announced that following the decision by former CEO Isaac Israel to step down from his CEO role and reduce the scope of his engagement with the Company for personal reasons, effective July 10, 2022, Gil Efron, will assume the CEO role.
- Isaac Israel will continue his involvement in the company and as a board member.
- Gil Efron joined the company in 2018 and has served as President and CFO of Purple Biotech since June 2021; prior to that he served as Deputy CEO and CFO.
For further details see:
Purple Biotech CEO steps down, internal executive appointed for new role